Skip to main content
logo
Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
14.07
-0.25 (-1.75%)
At close: Sep 11, 2026, 4:00 PM EDT
13.87
-0.20 (-1.42%)
After-hours: Sep 11, 2026, 7:39 PM EDT

Monte Rosa Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,2001,021426283368950
Market Cap Growth
304.92%139.48%50.74%-23.21%-61.22%-
Enterprise Value
617670228151142583
Last Close Price
14.0715.686.945.657.6120.42

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
41.798.265.64---
PB Ratio
2.464.381.911.581.362.73
P/TBV Ratio
2.464.381.911.581.362.73
P/FCF Ratio
--11.22---
P/OCF Ratio
--10.15---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
21.495.423.01---
EV/FCF Ratio
--6.00---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.080.170.190.260.17-
Debt / FCF Ratio
--1.12---
Net Debt / Equity Ratio
-1.20-1.45-1.48-1.04-0.79-1.00
Net Debt / EBITDA Ratio
3.367.374.511.361.994.89
Net Debt / FCF Ratio
18.1812.29-8.672.972.055.01
Asset Turnover
0.060.280.20---
Quick Ratio
10.496.052.375.0010.5820.80
Current Ratio
10.586.122.405.0710.7920.96
Return on Equity (ROE)
-42.66%-16.94%-36.15%-60.07%-35.06%-40.35%
Return on Assets (ROA)
-21.63%-7.64%-13.66%-27.72%-19.82%-21.92%
Return on Capital Employed (ROCE)
-28.80%-14.10%-28.80%-55.70%-35.50%-20.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-13.42%-3.78%-17.05%-47.85%-29.46%-7.79%
FCF Yield
-2.67%-2.69%8.91%-22.22%-28.61%-7.28%
Buyback Yield / Dilution
-11.90%-12.39%-43.80%-8.83%-88.91%-1548.09%
SEC Filings: 10-K · 10-Q